CA
NZ
UK
AU
IND
US
Watts Water Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 27, 2026, with the SEC on November 5, 2026, reporting third-quarter and nine-month financial results for fiscal year 2026.
Viatris Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
StealthGas Inc. filed a Form 6-K with the SEC on November 5, 2026, disclosing an agreement to acquire four LPG carriers from entities affiliated with the family of CEO Harry N. Vafias for an aggregate purchase price of $254.6 million.
Enrique Rodriguez, EVP and Chief Technology Officer of Liberty Global Ltd., filed a Form 4 on November 5, 2026, disclosing a purchase of Class A Common Shares on November 4, 2026.
Wolverine Asset Management, LLC and affiliated reporting persons filed Amendment No. 2 to their beneficial ownership statement with respect to Black Hawk Acquisition Corp. (NASDAQ:BKHA) on November 5, 2026, disclosing a 0.00% ownership position in the issuer's ordinary shares as of October 13, 2026.
T. Rowe Price filed a free writing prospectus on November 5, 2026, consisting of a transcript from a VettaFi webinar held November 2, 2026, in which T. Rowe Price's head of digital asset strategy discussed the T. Rowe Price Active Crypto ETF (NYSE:TKNZ) and …
Hudson Pacific Properties, Inc. filed a Form 8-K with the SEC on November 5, 2026, reporting the availability of its financial results and supplemental operating data for the third quarter ended September 30, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 5, 2026, disclosing terms for Market Linked Securities auto-callable with contingent coupon linked to the Class A common stock of Coinbase Global, Inc., due November 16, 2029.
DT filed an 8-K announcement on November 5, 2026, disclosing the appointment of Daniel Lentz as Chief Financial Officer, effective November 30, 2026, with Josh Kinsell continuing as Chief Accounting Officer.
HCW Biologics Inc. filed a current report on November 5, 2026, disclosing that it entered into a Notes Purchase Agreement with Streeterville Capital, LLC on November 3, 2026, providing for two secured promissory notes totaling $10.2 million in original principal.
Please wait processing your request...